A new study published in the JAMA Psychiatry gives the strongest evidence that semaglutide — the active ingredient in Ozempic ...

The new findings add to growing evidence that the medicines could help people with alcohol addiction. View on euronews ...

A new study has confirmed that weight loss or bariatric surgery is safe and very effective, and, for a large percentage of ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit — it could ...

Ozempic made headlines after a study came out linking this and similar medications like Wegovy to an eye condition that can cause irreversible damage and permanent vision loss, including total ...